Intratumoral Administration of Daromun in Non-melanoma Skin Cancer Patients
Conditions:   Carcinoma, Basal Cell;   Carcinoma, Cutaneous Squamous Cell Intervention:   Drug: L19IL2 +L19TNF Sponsor:   Philogen S.p.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2020 Category: Research Source Type: clinical trials

Interpolated Flap Study
Conditions:   Skin Cancer, Non-Melanoma;   Skin Cancer Melanoma;   Mohs Micrographic Surgery Intervention:   Sponsors:   University of Pennsylvania;   Oregon Health and Science University;   Stanford University;   University of Minnesota;   University of Missouri-Columbia;   University of Vermont;   University of Nebraska Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2019 Category: Research Source Type: clinical trials